Teladoc Health, Inc. (NYSE:TDOC) Shares Acquired by Wedmont Private Capital

Wedmont Private Capital raised its holdings in shares of Teladoc Health, Inc. (NYSE:TDOC) by 20.3% during the 1st quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 16,086 shares of the health services provider’s stock after acquiring an additional 2,715 shares during the period. Wedmont Private Capital’s holdings in Teladoc Health were worth $117,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors have also modified their holdings of the stock. Point72 Asset Management L.P. increased its position in shares of Teladoc Health by 33.6% during the 4th quarter. Point72 Asset Management L.P. now owns 11,179,863 shares of the health services provider’s stock valued at $101,625,000 after purchasing an additional 2,813,568 shares during the period. Maple Rock Capital Partners Inc. grew its holdings in Teladoc Health by 189.5% during the fourth quarter. Maple Rock Capital Partners Inc. now owns 3,561,000 shares of the health services provider’s stock worth $32,369,000 after acquiring an additional 2,331,000 shares during the period. Two Sigma Investments LP bought a new stake in Teladoc Health in the fourth quarter worth about $18,348,000. Two Sigma Advisers LP lifted its holdings in Teladoc Health by 213.0% in the 4th quarter. Two Sigma Advisers LP now owns 2,258,711 shares of the health services provider’s stock valued at $20,532,000 after acquiring an additional 1,537,094 shares during the last quarter. Finally, Vanguard Group Inc. boosted its position in shares of Teladoc Health by 5.9% during the 4th quarter. Vanguard Group Inc. now owns 18,463,155 shares of the health services provider’s stock valued at $167,830,000 after purchasing an additional 1,029,829 shares in the last quarter. 76.82% of the stock is currently owned by institutional investors.

Insider Activity at Teladoc Health

In other news, insider Adam C. Vandervoort sold 11,011 shares of the firm’s stock in a transaction dated Thursday, March 20th. The stock was sold at an average price of $8.42, for a total value of $92,712.62. Following the sale, the insider now directly owns 64,308 shares of the company’s stock, valued at approximately $541,473.36. This trade represents a 14.62% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, insider Carlos Nueno sold 3,958 shares of the stock in a transaction that occurred on Monday, June 2nd. The shares were sold at an average price of $6.86, for a total value of $27,151.88. Following the completion of the sale, the insider now directly owns 17,645 shares of the company’s stock, valued at $121,044.70. This represents a 18.32% decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last 90 days, insiders sold 29,667 shares of company stock valued at $220,901. Insiders own 0.58% of the company’s stock.

Analyst Upgrades and Downgrades

A number of research firms recently commented on TDOC. Canaccord Genuity Group dropped their target price on shares of Teladoc Health from $14.00 to $12.00 and set a “buy” rating on the stock in a report on Thursday, May 1st. Citigroup cut their price objective on Teladoc Health from $11.00 to $8.75 and set a “neutral” rating for the company in a research report on Friday, April 25th. Needham & Company LLC reissued a “hold” rating on shares of Teladoc Health in a research note on Thursday, May 1st. The Goldman Sachs Group decreased their price target on Teladoc Health from $13.00 to $10.00 and set a “buy” rating for the company in a research report on Thursday, May 1st. Finally, Truist Financial cut their price objective on Teladoc Health from $10.00 to $9.00 and set a “hold” rating on the stock in a report on Tuesday, May 27th. Twelve research analysts have rated the stock with a hold rating and seven have issued a buy rating to the company. Based on data from MarketBeat.com, the company currently has an average rating of “Hold” and a consensus price target of $9.60.

Teladoc Health Price Performance

Shares of NYSE:TDOC opened at $7.17 on Friday. The firm has a market cap of $1.26 billion, a price-to-earnings ratio of -1.24 and a beta of 1.78. The company has a current ratio of 1.73, a quick ratio of 1.69 and a debt-to-equity ratio of 0.66. Teladoc Health, Inc. has a 1 year low of $6.35 and a 1 year high of $15.21. The business has a fifty day simple moving average of $7.14 and a 200 day simple moving average of $9.05.

About Teladoc Health

Teladoc Health, Inc provides virtual healthcare services worldwide. The company operates through Teladoc Health Integrated Care and BetterHelp segments. The Integrated Care segment offers virtual medical services, including general medical, expert medical, specialty medical, chronic condition management, and mental health, as well as enabling technologies and enterprise telehealth solutions for hospitals and health systems.